Genetic control of the spontaneous activation of CD4+ Th cells in systemic lupus erythematosus-prone (NZB × NZW) F1 mice

Genes and Immunity

Volumn 7, Issue 8, 2006, Pages 647-654

  Fujii, T ^a   Iida, Y ^a   Yomogida, M ^a   Ikeda, K ^a   Haga, T ^a   Jikumaru, Y ^a   Ninami, M ^a   Nishimura, N ^a   Kodera, Y ^a   Inada, Y ^a   Shirai, T ^b   Hirose, S ^b   Nishimura, H ^a  

^a TOIN UNIVERSITY OF YOKOHAMA   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; LYMPHOCYTE ANTIGEN; NTA260 ANTIGEN; PADGEM PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CD4+ T LYMPHOCYTE; CHROMOSOME 12; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE FREQUENCY; GENE FUNCTION; GENE INTERACTION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HELPER CELL; HYBRID; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE COUNT; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MEMORY CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS MAPPING; SPLEEN LYMPHOCYTE; STRAIN DIFFERENCE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

AGE FACTORS; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; AUTOIMMUNITY; CHROMOSOME MAPPING; CROSSES, GENETIC; FLOW CYTOMETRY; L-SELECTIN; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED NZB; MICROSATELLITE REPEATS; QUANTITATIVE TRAIT LOCI; SPLEEN; T-LYMPHOCYTES, HELPER-INDUCER;

MURINAE; MUS;

EID: 33846956830     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364342     Document Type: Article

References (55)

1. Bielschowsky M, Helyer BJ, Howie JB. Spontaneous haemolytic anemia in mice of the NZB/B1 strain. Proc Univ Otago Med Sch 1959; 37: 9-11.
2. Helyer BJ, Howie JB. Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature 1963; 197: 197.
3. Shirai T, Hirose S, Okada T, Nishimura H. Immunology and immunopathology of the autoimmune disease of NZB and related mouse strains. In: Rihova B, Vetvicka V (eds). Immunological Disorders in Mice. CRC Press: Boca Raton, FL, 1991, pp 96-136.
4. Kelley VE, Winkelstein A. Age- and sex-related glomerulonephritis in New Zealand white mice. Clin Immunol Immunopathol 1980; 16: 142-150.
5. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol 1985; 37: 269-390.
6. Hayakawa K, Hardy RR, Parks DR, Herzenberg LA. The 'Ly-1 B' cell subpopulation in normal, immunodefective, and autoimmune mice. J Exp Med 1983; 157: 202-218.
7. Herzenberg LA, Stall AM, Lalor PA, Sidman C, Moore WA, Parks DR et al. The Ly-1 B cell lineage. Immunol Rev 1986; 93: 81-102.
8. Hirose S, Jiang Y, Hamano Y, Shirai T. Genetic aspects of inherent B-cell abnormalities associated with SLE and B-cell malignancy: Lessons from New Zealand mouse models. Int Rev Immunol 2000; 19: 389-421.
9. Hirose S, Nagasawa R, Sekigawa I, Hamaoki M, Ishida Y, Sato H et al. Enhancing effect of H-2-linked NZW gene(s) on the autoimmune traits of (NZBbNZW) F1 mice. J Exp Med 1983; 158: 228-233.
10. Hirose S, Ueda G, Noguchi K, Okada T, Sekigawa I, Sato H et al. Requirement of H-2 heterozygosity for autoimmunity in (NZB × NZW) F1 hybrid mice. Eur J Immunol 1986; 16: 1631-1633.
11. Taki S, Hirose S, Kinoshita K, Nishimura H, Shimamura T, Hamuro J et al. Somatically mutated IgG anti-DNA antibody clonally related to germ-line encoded IgM anti-DNA antibody. Eur J Immunol 1992; 22: 987-992.
12. Hirose S, Wakiya M, Kawano-Nishi Y, Yi J, Sanokawa R, Taki S et al. Somatic diversification and affinity maturation of IgM and IgG anti-DNA antibodies in murine lupus. Eur J Immunol 1993; 23: 2813-2820.
13. + T-cell clones. Immunology 1994; 83: 221-226.
14. + T cells expressing early activation antigen CD69 in murine lupus: Possible abnormal regulatory role for cytokine imbalance. J Immunol 1998; 161: 1267-1273.
15. Ohgaki M, Ueda G, Shiota J, Nishimura H, Hirose S, Sato H et al. Two distinct monoclonal natural thymocytotoxic auto-antibodies from New Zealand black mouse. Clin Immunol Immunopathol 1989; 53: 475-487.
16. + T cell subsets defined by expression of CD45RC and NTA260 antigens and age-associated polarization in murine lupus. Int Immunol 1995; 7: 1115-1123.
17. Alcocer-Varela J, Alarcon-Segovia D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 1982; 69: 1388-1392.
18. Linker-Israeli M, Bakke AC, Kitridou RC, Gendler S, Gillis S, Horwitz DA. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol 1983; 130: 2651-2655.
19. Murakawa Y, Takada S, Ueda Y, Suzuki N, Hoshino T, Sakane T. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus. J Immunol 1985; 134: 187-195.
20. Huang Y-P, Miescher PA, Zubler RH. The interleukin 2 secretion defect in vitro in systemic lupus erythematosus is reversible in restricted cultured T cells. J Immunol 1986; 137: 3515-3520.
21. + T cell abnormality in patients with active systemic lupus erythematosus: HLADR antigen expressions. Clin Immunol Immunopathol 1988; 48: 42-49.
22. Spronk PE, Horst G, Van der Gun BTF, Limburg PC, Kallenberg CGM. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE). Clin Exp Immunol 1996; 104: 446-453.
23. + T cells and deficient interleukin-2 production in patients with systemic lupus erythematosus. Clin Immunol Immunopathol 1990; 55: 285-296.
24. Viallard FJ, Bloch-Michel C, Neau-Cransac M, Taupin JL, Garrigue V, Miossec Vet al. HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus. Clin Exp Immunol 2001; 125: 485-491.
25. Morimoto C, Reinherz EL, Distaso JA, Steinberg AD, Schlossman SF. Relationship between systemic lupus erythematosus T cell subsets, anti-T cell antibodies, and T cell functions. J Clin Invest 1984; 73: 689-700.
26. + cells in systemic lupus erythematosus and Sjogren's syndrome. Arthritis Rheum 1987; 30: 1407-1411.
27. Imhof B, Dunon D. Leukocyte migration and adhesion. Adv Immunol 1995; 58: 345-416.
28. Otto J. Analysis of human genetic linkage, 3rd edn. The Johns Hopkins University Press: Baltimore, MD, 1999, pp 280-291.
29. Manly KF, Olson JM. Overview of QTL mapping software and introduction to map manager QT. Mamm Genome 1999; 10: 327-334.
30. Lander E, Kruglyak L. Genetic dissection of complex traits: Guidelines for interpreting and reporting linkage results. Nat Genet 1995; 11: 241-247.
31. Wofsy D, Seaman WE. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J Exp Med 1985; 161: 378-391.
32. Sekigawa I, Ishida Y, Hirose S, Sato H, Shirai T. Cellular basis of in vitro anti-DNA antibody production: Evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB × NZW)F1 hybrid. J Immunol 1986; 136: 1247-1252.
33. Sekigawa I, Okada T, Noguchi K, Ueda G, Hirose S, Sato H et al. Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB × NZW) F1 hybrid mice. J Immunol 1987; 138: 2890-2895.
34. Nishimura H, Ishikawa S, Nozawa S, Awaji M, Saito J, Abe M et al. Effects of transgenic mixed-haplotype MHC class II molecules AadAbz on autoimmune disease in New Zealand mice. Int Immunol 1996; 8: 967-976.
35. Zhang D, Fujio K, Jiang Y, Zhao J, Tada N, Sudo K et al. Dissection of the role of MHC class II A and E genes in autoimmune susceptibility in murine lupus models with intragenic recombination. Proc Natl Acad Sci USA 2004; 101: 13838-13843.
36. Graham RR, Ortmann WA, Langefeld CD, Jawaheer D, Selby SA, Rodine PR et al. Visualizing human leukocyte antigen class II risk haplotypes in human systemic lupus erythematosus. Am J Hum Genet 2002; 71: 543-553.
37. Quayle A, Kieldsen-Kragh J, Forre O, Waalen K, Sioud M, Kalvenes C et al. Immunoregulatory T cell subsets and T cell activation in rheumatoid arthritis. A need for analysis on the clonal and molecular level. Springer Semin Immunopathol 1989; 11: 273-287.
38. Fox RI, Howell FV, Bone RC, Micheloson P. Primary Sjogren syndrome: clinical and immunopathologic feature. Semin Arthritis Rheum 1984; 14: 77-105.
39. Tokushige K, Hirose S, Nishimura H, Fujimori M, Yamauchi K, Obata H et al. Abnormal T cell activation and skewed T cell receptor V β repertoire usage in Japanese patients with idiopathic portal hypertension. Clin Immunol Immunopathol 1995; 75: 206-213.
40. Bolland S, Ravetch JV. Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis. Immunity 2000; 13: 277-285.
41. Bolland S, Yim YS, Tus K, Wakeland EK, Ravetch JV. Genetic modifiers of systemic lupus erythematosus in FcRIIB(-/-) mice. J Exp Med 2002; 195: 1167-1174.
42. + anti-DNA plasma cells. Nat Immunol 2005; 6: 99-106.
43. Jiang Y, Hirose S, Sanokawa-Akakura R, Abe M, Mi X, Li N et al. Genetically determined aberrant down-regulation of FcγRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int Immunol 1999; 11: 1685-1691.
44. Jiang Y, Hirose S, Abe M, Sanokawa-Akakura R, Ohtsuji M, Mi X et al. Polymorphisms in IgG Fc receptor IIB regulatory regions associated with autoimmune susceptibility. Immunogenetics 2000; 51: 429-435.
45. Xiu Y, Nakamura K, Abe M, Li N, Wen XS, Jiang Y et al. Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J Immunol 2002; 169: 4340-4346.
46. Rigby RJ, Rozzo SJ, Boyle J, Lewis M, Kotzin BL, Vyse TJ. New loci from New Zealand Black and New Zealand White on chromosome 4 and 12 contribute to lupus-like disease in the context of BALB/c. J Immunol 2004; 172: 4609-4617.
47. Krulova M, Havelkova H, Kosarova M, Holan V, Hart AA, Demant P et al. IL-2-induced proliferative response is controlled by loci Cinda1 and Cinda2 on mouse chromosomes 11 and 12: A distinct control of the response induced by different IL-2 concentrations. Genomics 1997; 42: 11-15.
48. Nagase H, Mao JH, Balmain A. A subset of skin tumor modifier loci determines survival time of tumor-bearing mice. Proc Natl Acad Sci USA 1999; 96: 15032-15037.
49. Jackson AU, Galeck AT, Burke DT, Miller RA. Genetic polymorphisms in mouse genes regulating age-sensitive and age-stable Tcell subsets. Genes Immun 2003; 4: 30-39.
50. Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, Lanier LL et al. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 2006; 440: 540-544.
51. Baechler EC, Gregersen PK, Behrens TW. The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol 2004; 16: 801-807.
52. Sambrook J, Fritsch EF, Maniatis T. Isolation of high-molecular-weight DNA from mammalian cells. In: Ford N, Nora C, Ferguson M (eds). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1989, pp 9-14.
53. Dietrich W, Katz H, Lincoln SE, Shin HS, Friedman J, Dracopoli NC et al. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 1992; 131: 423-447.
54. Ogasawara M, Sugimori H, Iida Y, Yoshida K. Analysis between lifestyle, family medical history and medical abnormalities using data mining method - association rule analysis. In: Khosla R, Howlett RJ, Jain LC (eds). Knowledge-Based Intelligent Information and Engineering Systems, 9th International Conference, KES 2005, Melbourne, Australia, 14-16 September, 2005, Proceedings, Part II, Lecture Notes in Artificial Intelligence (Subseries of Lecture Notes in Computer Science), Vol. 3682. Springer-Verlag: New York, NY, 2005, pp 161-171.
55. Agrawal R, Imielinski T, Swami A. Mining association rules between sets of items in large databases. ACM SIGMOD 1993; 22: 207-216.